Filtered By:
Condition: Atrial Fibrillation
Drug: Pradaxa
Countries: Turkey Health

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 43 results found since Jan 2013.

Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT).
CONCLUSION: Potential results of D-SPIRIT registry will add data from clinical practice to those from the RE-LY trial to expand knowledge of dabigatran etexilate treatment in patients with NVAF. PMID: 27138311 [PubMed - in process]
Source: Turk Kardiyoloji Dernegi arsivi - March 31, 2016 Category: Cardiology Authors: Türk UÖ, Alioğlu E, Tunçer E, Özpelit ME, Pekel N, Tengiz İ, Çetin N, Dalgıç O, Topaloğlu C, Bilgin N, Altın C, Özdemirkıran T, Tülüce K, Türkoğlu Eİ, Özpelit E Tags: Turk Kardiyol Dern Ars Source Type: research

Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry
CONCLUSION: This registry obtained an important overview of the current safety and effectiveness of the dabigatran etexilate in Turkey. Our results indicate similar rates of thromboembolic and bleeding events with pivotal phase 3 trial and other real-life registries. However, rate of undertreatment usage of dabigatran etexilate in real life was found to be considerable.PMID:34881702 | DOI:10.5543/tkda.2021.07734
Source: Turk Kardiyoloji Dernegi arsivi - December 9, 2021 Category: Cardiology Authors: Cihan Alt ın Caner Topalo ğlu Nurullah Çetin Onur Dalg ıç Veysel Yavuz Emin Alio ğlu Nazile Bilgin Cenk Ekmek çi Nihat Pekel Mehmet Emre Özpelit E şref Tunçer Ebru İpek Türkoğlu Kamil T ülüce Umut Kocaba ş K ıvanç Yüksel U ğur Önsel T Source Type: research